MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,529,000 | -14.4% | 91,698 | +5.6% | 0.00% | 0.0% |
| Q3 2016 | $1,787,000 | -20.3% | 86,815 | +18.5% | 0.00% | 0.0% |
| Q2 2016 | $2,242,000 | -18.4% | 73,248 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $2,749,000 | +39.8% | 73,460 | +61.1% | 0.00% | 0.0% |
| Q4 2015 | $1,967,000 | +11.9% | 45,592 | -2.8% | 0.00% | 0.0% |
| Q3 2015 | $1,758,000 | +33.0% | 46,899 | +20.6% | 0.00% | 0.0% |
| Q2 2015 | $1,322,000 | -21.5% | 38,900 | -18.2% | 0.00% | 0.0% |
| Q1 2015 | $1,685,000 | +2.6% | 47,583 | -1.4% | 0.00% | 0.0% |
| Q4 2014 | $1,643,000 | -2.3% | 48,245 | +10.6% | 0.00% | 0.0% |
| Q3 2014 | $1,682,000 | -27.2% | 43,626 | -26.5% | 0.00% | 0.0% |
| Q2 2014 | $2,310,000 | -75.9% | 59,381 | -78.8% | 0.00% | -83.3% |
| Q1 2014 | $9,595,000 | +92.5% | 280,654 | +18.2% | 0.01% | +100.0% |
| Q4 2013 | $4,984,000 | -8.3% | 237,500 | +2.7% | 0.00% | -25.0% |
| Q3 2013 | $5,434,000 | +16.6% | 231,277 | +33.3% | 0.00% | 0.0% |
| Q2 2013 | $4,660,000 | – | 173,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |